✦ LIBER ✦

Disease modification in multiple sclerosis: Issues with relevance to clinical trial designs in Alzheimer’s disease

✍ Scribed by Richard A. Rudick

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ethical Issues in Clinical Drug Trials i

✍ Elizabeth G. Cleland; Carol A. Snellgrove; Jane R. Hecker 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB

S5-03-02 Prevention trials in Alzheimer'

✍ Leon Thal 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Clinical relevance in drug trials for Al

✍ Alberto Spagnoli 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB 👁 2 views

Challenges to demonstrating disease-modi

✍ Jeffrey L. Cummings 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 229 KB

T-Lymphocyte subsets modifications in mu

✍ M. Prencipe; E. Salerni; C. D'Aurizio; C. Marini; D. Adorno; A M. Berghella; P. 📂 Article 📅 1986 🏛 Springer Milan 🌐 English ⚖ 363 KB

P-194: Modification of the staggered sta

✍ Suzanne Hendrix; Alexander Gutin; Kenton Zavitz; Graham Carron; Mark Laughlin; S 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 190 KB